原发性恶性卵巢类癌:管理与结局
基于美国国家癌症数据库2004至2015年588例原发性恶性卵巢类癌患者,中位年龄51.5岁,多数为单侧肿瘤且局限于卵巢。早期患者5年总生存率95.4%,晚期为53.1%,早期行单侧输卵管卵巢切除术似可治愈。
要点
- 卵巢类癌多为单侧、局限于卵巢的小肿瘤,常见于围绝经期患者。
- 早期患者5年总生存率95.4%,晚期(II-IV期)为53.1%。
- 早期患者行单侧输卵管卵巢切除术似可治愈,子宫切除与否不影响生存。
核心结论
- 卵巢类癌通常为局限于卵巢的单侧小肿瘤,早期患者生存极佳,单侧输卵管卵巢切除术似可治愈。
研究设计与样本
- 回顾性队列研究,利用美国国家癌症数据库纳入2004至2015年确诊的原发性卵巢类癌患者,排除其他部位肿瘤个人史,共588例,中位年龄51.5岁。
主要发现
- 多数患者为白人(71.6%),单侧肿瘤(94.2%),中位肿瘤大小3.8 cm,肿瘤局限于卵巢(88%)。
- 早期患者(n=431)与晚期(II-IV期)患者(n=51)的总生存差异显著,p<0.001;5年总生存率分别为95.4%和53.1%。
- I期患者中,行子宫切除术(n=211)与未行子宫切除术(n=175)的总生存无差异,p=0.92。
- 晚期患者中,辅助化疗与更好的生存无关,p=0.093。
临床怎么用
- 对于早期卵巢类癌,单侧输卵管卵巢切除术可作为治愈性手段,无需常规行子宫切除。
- 晚期患者辅助化疗未见生存获益,需个体化决策。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the clinicopathological characteristics and survival of patients with malignant ovarian carcinoid tumor (OC). MATERIALS AND METHODS: The National Cancer Database was accessed and patients diagnosed between 2004 and 2015 with a OC who did not have a personal history of a tumor at another site were selected. Overall survival (OS) was assessed for patients who had ≥1 month of follow-up. OS rates were estimated following generation of Kaplan-Meier curves and compared with the log-rank test. RESULTS: A total of 588 patients with a median age of 51.5 years were identified. The majority were White (71.6%), had unilateral tumors (94.2%) with a median size of 3.8 cm that were confined to the ovary (88%). Patients with early stage disease (n = 431) had excellent OS compared to those with advanced stage (II-IV) disease (n = 51), p < 0.001; 5-yr OS rates were 95.4% and 53.1% respectively. For patients with stage I disease, there was no difference in OS between those who did (n = 211) and did not (n = 175) have hysterectomy, p = 0.92. For patients with advanced stage disease, administration of adjuvant chemotherapy was not associated with better survival, p = 0.093. CONCLUSIONS: OCs are typically small, unilateral tumors confined to the ovary arising in perimenopausal patients. Survival outcomes are excellent for patients with early stage disease and unilateral salpingo-oophorectomy appears to be curative.
引用
- Nasioudis D, Frey MK, Chapman-Davis E, et al. Primary malignant ovarian carcinoid; management and outcomes. Gynecol Oncol. 2020. PMID: 31959493. doi:10.1016/j.ygyno.2020.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。